Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Potassium Iodide Stockpiling Guidelines Called For In Bioterrorism Bill

This article was originally published in The Tan Sheet

Executive Summary

Within a year of enacting bioterrorism legislation, the Bush Administration will consult with federal, state and local agencies to establish guidelines for the stockpiling of potassium iodide (KI) tablets

You may also be interested in...



Bioterrorism Efforts At Forefront Of CFSAN Activities; GMPs Remain Priority

Four separate workgroups within FDA's Center for Food Safety & Applied Nutrition have been formed to implement food-related provisions of the bioterrorism act, CFSAN Director Joseph Levitt said July 17

Bioterrorism Efforts At Forefront Of CFSAN Activities; GMPs Remain Priority

Four separate workgroups within FDA's Center for Food Safety & Applied Nutrition have been formed to implement food-related provisions of the bioterrorism act, CFSAN Director Joseph Levitt said July 17

Bioterrorism Efforts At Forefront Of CFSAN Activities; GMPs Remain Priority

Four separate workgroups within FDA's Center for Food Safety & Applied Nutrition have been formed to implement food-related provisions of the bioterrorism act, CFSAN Director Joseph Levitt said July 17

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094065

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel